Quest Diagnostics - Press Releases

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996

Quest Diagnostics Care360™ Named Top e-Prescribing Platform by Black Book Rankings

12/09/11

One in Three First-Time Participants in Laboratory-Based Wellness Program Learn of High Risk for Chronic Disease, Quest Diagnostics Study Shows

12/08/11

Quest Diagnostics Adds Timothy M. Ring to Board of Directors

12/07/11

Quest Diagnostics Launches Simplexa™ Dengue Test in Brazil, First Commercial Molecular Test Approved for Nation's Public and Private Health Testing

12/06/11

Quest Diagnostics CE Marks Simplexa(TM) Test for Cytomegalovirus for Sale in Europe

11/15/11

Quest Diagnostics to Speak at the Lazard Capital Markets 8th Annual Healthcare Conference

11/11/11

Quest Diagnostics Encourages Denver Area Residents to Enroll in Historic American Cancer Society Prevention Study November 8th - 19th

11/08/11

Quest Diagnostics Announces Launch of Simplexa(TM) Direct Test for Influenza and Respiratory Viruses in Europe

11/01/11

Quest Diagnostics Reports Third Quarter 2011 Financial Results

10/25/11

Quest Diagnostics Increases Quarterly Cash Dividend

10/25/11

Quest Diagnostics Initiates CEO Succession Process

10/25/11

Quest Diagnostics to Release Third Quarter 2011 Financial Results

10/13/11

Hydrocodone and Oxycodones Lead U.S. General Workforce Positives, Outranked Only by Marijuana, According to Quest Diagnostics Drug Testing Index(TM)

10/11/11

Quest Diagnostics Named Healthiest Employer in Philadelphia, Baltimore and Washington, D.C. Regions

09/27/11

New Rules Opening Access to Lab Test Results Will Empower Patients to Understand Their Health Better

09/13/11

Quest Diagnostics Selected as Member of Dow Jones® Sustainability Index

09/09/11

Quest Diagnostics to Speak at the Morgan Stanley Global Healthcare Conference

09/08/11

Hawaii, Arkansas and Oklahoma Lead the Nation for Methamphetamine Use in the Workforce, Reveals Quest Diagnostics Drug Testing Index(TM)

09/02/11

Quest Diagnostics Declares Quarterly Cash Dividend

08/12/11

Quest Diagnostics to Unveil Extensions to its Women's Health and Personalized Medicine Test Offerings at the 2011 AACC Annual Meeting and Clinical Lab Expo

07/25/11

Quest Diagnostics Reports Second Quarter 2011 Financial Results

07/20/11

Quest Diagnostics and Genomic Vision Form Strategic Collaboration to Develop Genome-based Laboratory Tests

07/14/11

Quest Diagnostics to Release Second Quarter 2011 Financial Results

07/06/11

Poll: One in Three Adults 60-70 Years of Age Screened for Colon Cancer Have Only Done So Once, Suggesting Failure to Follow Periodic Testing Guidelines

06/27/11

Quest Diagnostics Gazelle® Mobile Health Platform Now Available for Android Smartphones

06/22/11

Nearly One in Three Men and Women Age 50 and Over Have Not Been Screened for Colon Cancer; One in Four Say their Healthcare Provider Didn't Recommend Screening

06/16/11

Quest Diagnostics Wins Gold Medical Design Excellence Award (MDEA) for Diagnostic Innovation

06/09/11

Quest Diagnostics to Speak at the Jefferies 2011 Global Healthcare Conference

06/03/11

Men May Have Greater Allergy Risk Than Women, Suggests Largest Ever National Allergy Study

05/25/11

Quest Diagnostics Earns Platinum Honor as "Best Employer for Healthy Lifestyles" for Third Consecutive Year

05/24/11

OVA1 Improves Ovarian Cancer Detection Over CA 125 Blood Test and Clinical Assessment

05/24/11

Ragweed and Mold Lead Overall Upswing in Allergy Prevalence; Climate Change Suspected

05/23/11

Quest Diagnostics Finalizes Agreement to Settle California Lawsuit Related to Medi-Cal Billing

05/19/11

Quest Diagnostics Successfully Completes Acquisition of Celera

05/17/11

Quest Diagnostics Declares Quarterly Cash Dividend

05/17/11

Food Allergies Common among Children and Linked to Environmental Allergies and Asthma Later in Life, Suggests Largest-Ever National Allergy Study

05/17/11

OVA1 Blood Test Detects Ovarian Cancer More Accurately Than Medically Accepted CA 125 Method for Evaluating Women with Ovarian Mass

05/12/11

Quest Diagnostics to Speak at the Bank of America Merrill Lynch 2011 Healthcare Conference

05/11/11

Quest Diagnostics Announces Completion of Final Extension of the Subsequent Offering Period and Intent to Exercise Top-Up Option and Complete Merger

05/11/11

Quest Diagnostics Reaches Agreement in Principle to Settle California Lawsuit Related to Medi-Cal Billing

05/09/11

Quest Diagnostics Sponsors American Cancer Society's Choose You® Movement

05/09/11

Quest Diagnostics Announces Final Extension of Subsequent Offering Period for Shares of Celera

05/09/11

Quest Diagnostics Care360 EHR Customer Successfully Completes Meaningful Use Attestation to Receive the Medicare EHR Incentive

05/06/11

Quest Diagnostics Launches Simplexa(TM) C. Difficile Universal Direct Test in Europe

05/05/11

Quest Diagnostics Announces Successful Tender Offer and Commencement of a Subsequent Offering Period for Shares of Celera

05/04/11

Quest Diagnostics to Speak at the Deutsche Bank 36th Annual Healthcare Conference

05/03/11

Quest Diagnostics Announces One Day Extension of Offer to Acquire Celera to 5pm Today

05/03/11

Quest Diagnostics CE Marks Simplexa(TM) Tests for Epstein Barr and BK Viruses for Sale in Europe

04/28/11

Quest Diagnostics Reports First Quarter 2011 Financial Results

04/20/11

Quest Diagnostics Extends Tender Offer for all Outstanding Shares of Celera Corporation to May 2, 2011

04/18/11

Quest Diagnostics Launches Hepatitis C Virus Therapy Test Based on IL28B Gene Variants

04/18/11

Quest Diagnostics Announces HSR Clearance for the Acquisition of Celera

04/13/11

Quest Diagnostics to Release First Quarter 2011 Financial Results

04/12/11

Quest Diagnostics Honored for Diagnostic Innovation at 2011 Edison Awards

04/06/11

Quest Diagnostics Completes Acquisition of Athena Diagnostics

04/04/11

Quest Diagnostics Commences Tender Offer for Acquisition of Celera

03/28/11

Quest Diagnostics Launches National Electronic Health Records Awareness Tour Showcasing Care360 EHR

03/22/11

Quest Diagnostics Incorporated Announces Proposed Senior Notes Offering

03/21/11

Quest Diagnostics to Acquire Celera, Strengthening Position as World's Leading Innovator in Molecular Diagnostics and Development

03/18/11

New York State Approves the Quest Diagnostics ColoVantage(TM) Colorectal Cancer Blood Test

03/17/11

Quest Diagnostics to Speak at the Barclays Capital 2011 Global Healthcare Conference

03/14/11

Quest Diagnostics Ranked Among FORTUNE Magazine's 'World's Most Admired Companies' for Fourth Consecutive Year

03/04/11

Quest Diagnostics to Speak at the Citi 2011 Global Healthcare Conference

02/28/11

Quest Diagnostics to Acquire Athena Diagnostics, Establishing Leading Position in Rapidly Growing Neurology Testing Market

02/24/11

Quest Diagnostics Care360(TM) Becomes First Certified, Commercially Available EHR to Include Direct Project Specifications

02/22/11

Quest Diagnostics Declares Quarterly Cash Dividend

02/16/11

Quest Diagnostics and Withings Announce Availability of Integrated WiFi Weight Tracking for the Gazelle Mobile Health Platform

02/10/11

Quest Diagnostics to Speak at the UBS Global Healthcare Services Conference 2011

02/02/11

Quest Diagnostics Announces Pricing in Offering of Common Stock by the Company's Largest Shareholder

02/01/11

/C O R R E C T I O N -- Quest Diagnostics Incorporated/

01/31/11

Quest Diagnostics Agrees to Repurchase 15.4 Million Shares From Largest Shareholder

01/31/11

Quest Diagnostics Announces Offering of Common Stock by the Company's Largest Stockholder

01/31/11

Oral Fluid Reveals More Heroin Use Than Previously Believed, According to Quest Diagnostics Drug Testing Index

01/25/11

Quest Diagnostics Reports Fourth Quarter 2010 Financial Results; Provides Guidance for 2011

01/25/11

Quest Diagnostics Increases Share Repurchase Authority by $750 Million

01/25/11

Quest Diagnostics to Release Fourth Quarter and Full Year 2010 Financial Results

01/13/11